Your Health Plan:
Your Health Plan:
Not SelectedSYNAGIS (palivizumab ) is a biologic prescription drug for treatment of Congenital Heart Disease, Bronchopulmonary Dysplasia and Critical congenital heart disease. SYNAGIS is a respiratory syncytial virus anti-f protein monoclonal antibody. It is available in the form of intramuscular injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $1800-4500.
Patient Assistance Prorgams and Coupons are found:
No other option is found for SYNAGIS